Published in Tech Coloproctol on January 15, 2014
Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell (2015) 3.67
Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia. J Neurogastroenterol Motil (2015) 1.01
The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J Mol Psychiatry (2014) 0.88
Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance. Sci Rep (2015) 0.79
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. J Neurogastroenterol Motil (2016) 0.79
Enteric Neuronal Regulation of Intestinal Inflammation. Trends Neurosci (2016) 0.79
Irritable bowel syndrome is associated not only with organic but also psychogenic erectile dysfunction. Int J Impot Res (2015) 0.78
Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome. World J Gastroenterol (2014) 0.78
Electroacupuncture versus Moxibustion for Irritable Bowel Syndrome: A Randomized, Parallel-Controlled Trial. Evid Based Complement Alternat Med (2015) 0.78
Olanzapine May Inhibit Colonic Motility Associated with the 5-HT Receptor and Myosin Light Chain Kinase. Psychiatry Investig (2016) 0.76
Irritable bowel syndrome and chronic constipation: Fact and fiction. World J Gastroenterol (2015) 0.75
What goes around comes around: novel pharmacological targets in the gut-brain axis. Therap Adv Gastroenterol (2016) 0.75
Role of principal ionotropic and metabotropic receptors in visceral pain. J Neurogastroenterol Motil (2015) 0.75
Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P. World J Gastroenterol (2015) 0.75
Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats. Am J Transl Res (2016) 0.75
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study. J Neurogastroenterol Motil (2017) 0.75
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81
The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology (2003) 3.59
The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation. Br J Pharmacol Chemother (1959) 3.17
Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci (1980) 2.53
Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther (1999) 2.28
Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology (2012) 2.11
Molecular biology of 5-HT receptors. Neuropharmacology (1994) 2.01
Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol (2000) 1.93
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 1.93
Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci (2004) 1.91
The 5-HT3 receptor as a therapeutic target. Expert Opin Ther Targets (2007) 1.86
Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology (2006) 1.85
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp (2004) 1.76
Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine. Neurogastroenterol Motil (2011) 1.75
Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects. Gut (1990) 1.70
Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum. Neurogastroenterol Motil (2002) 1.70
Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev (1999) 1.69
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut (1998) 1.62
A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci (1993) 1.59
Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc (1992) 1.53
Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta. Proc Natl Acad Sci U S A (1992) 1.50
Rectal hypersensitivity in the irritable bowel syndrome. Int J Colorectal Dis (1997) 1.44
Visceral hypersensitivity: facts, speculations, and challenges. Gut (2001) 1.42
Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists. Proc Natl Acad Sci U S A (1986) 1.39
Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology (1997) 1.37
Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion (2001) 1.35
Fundamentals of neurogastroenterology: basic science. Gastroenterology (2006) 1.34
Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc Natl Acad Sci U S A (1993) 1.34
Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol (2001) 1.29
An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut (2001) 1.26
Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol (2002) 1.25
Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology (2003) 1.23
Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut (2000) 1.23
Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus. Mol Pharmacol (1992) 1.22
Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience (1987) 1.22
Afferent pain pathways: a neuroanatomical review. Brain Res (2004) 1.21
Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. Proc Natl Acad Sci U S A (1992) 1.19
Gut pacemaker cells: the interstitial cells of Cajal (ICC). J Smooth Muscle Res (2003) 1.19
Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem (2006) 1.19
Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries. Mol Pharmacol (1993) 1.18
Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs (2001) 1.17
Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J (1992) 1.14
Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil (2009) 1.14
The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br J Pharmacol (2004) 1.12
5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice. Am J Physiol Gastrointest Liver Physiol (2002) 1.09
Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain. Neuroscience (1999) 1.09
A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci (2008) 1.08
The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain (2004) 1.08
Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut (1998) 1.08
Characterization of the human 5-hydroxytryptamine1B receptor. J Biol Chem (1992) 1.06
Prucalopride. Drugs (2009) 1.05
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database Syst Rev (2007) 1.05
Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist. Aliment Pharmacol Ther (1990) 1.05
Identification of cells that express 5-hydroxytryptamine1A receptors in the nervous systems of the bowel and pancreas. J Comp Neurol (1996) 1.04
Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome. Neurogastroenterol Motil (2002) 1.04
BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology (1997) 1.04
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol (2012) 1.03
Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans. Neurogastroenterol Motil (2007) 1.03
Mechanisms of action of the 5-HT1B/1D receptor agonists. Arch Neurol (2002) 1.03
Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers. Aliment Pharmacol Ther (2000) 1.02
5-HT7 receptors. Curr Drug Targets CNS Neurol Disord (2004) 1.02
Review article: tegaserod. Aliment Pharmacol Ther (2001) 0.99
Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.99
5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord. Eur J Pharmacol (1989) 0.98
5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals. Brain Res (1993) 0.98
Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats. Neurosci Res (1991) 0.97
Differential modulation of the 5-HT(4) receptor agonists and antagonist on rat learning and memory. Neuropharmacology (2000) 0.97
Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat. Brain Res (1991) 0.97
Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans. Gut (2002) 0.97
CGRP as a transmitter in the sensory pathway mediating peristaltic reflex. Am J Physiol (1994) 0.96
The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family. EMBO J (1992) 0.94
Basic pathophysiologic mechanisms in irritable bowel syndrome. Dig Dis (2001) 0.94
5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro. Br J Pharmacol (2002) 0.93
Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord (2003) 0.92
The relationship between somatisation and outcome in patients with severe irritable bowel syndrome. J Psychosom Res (2008) 0.92
Serotonin augments gut pacemaker activity via 5-HT3 receptors. PLoS One (2011) 0.92
Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain. Trends Pharmacol Sci (1990) 0.91
Human 5-HT(5) receptors: the 5-HT(5A) receptor is functional but the 5-HT(5B) receptor was lost during mammalian evolution. Eur J Pharmacol (2001) 0.90
5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology (2005) 0.90
5-Hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur J Pharmacol (1993) 0.89
5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors. Neurogastroenterol Motil (2005) 0.89
5-HT receptors mediating contractions of the isolated human coronary artery. Eur J Pharmacol (1993) 0.88
Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype. J Biol Chem (1992) 0.87
Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron). Digestion (1997) 0.87
Serotonin receptor activation of phosphoinositide turnover in uterine, fundal, vascular, and tracheal smooth muscle. J Cardiovasc Pharmacol (1987) 0.87
Localization of 5-ht(5A) receptor-like immunoreactivity in the rat brain. Brain Res (2000) 0.86
Age and sex effects on 5-HT(4) receptors in the human brain: a [(11)C]SB207145 PET study. J Cereb Blood Flow Metab (2011) 0.85
5-HT(4) receptors, a place in the sun: act two. Curr Opin Pharmacol (2011) 0.84
A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders. J Neural Transm (Vienna) (2007) 0.83
Central processing of rectal pain: a functional MR imaging study. AJNR Am J Neuroradiol (2000) 0.83
In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors. Pol J Pharmacol (2003) 0.82
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome. Int J Colorectal Dis (2013) 0.82
Mast cell expression of the serotonin1A receptor in guinea pig and human intestine. Am J Physiol Gastrointest Liver Physiol (2013) 0.81
Sex differences of brain serotonin synthesis in patients with irritable bowel syndrome using alpha-[11C]methyl-L-tryptophan, positron emission tomography and statistical parametric mapping. Can J Gastroenterol (2003) 0.80
Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: relation to serotonin and psychological state. J Psychosom Res (2013) 0.80
The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations. J Pharmacol Exp Ther (2012) 0.79
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut (2005) 3.31
Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest (2006) 3.17
Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes. Mol Biol Cell (1999) 2.80
Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis (2003) 2.79
Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75
Neurofibromatosis type 1 growth charts. Am J Med Genet (1999) 2.32
Chloracne due to o-dichlorobenzene in a laboratory worker. Contact Dermatitis (2005) 2.02
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol (1998) 2.01
Endoscopic treatment of gastrointestinal fistulas using an over-the-scope clip (OTSC) device: case series from a tertiary referral center. Endoscopy (2011) 1.83
Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest (1992) 1.71
Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol (1996) 1.68
Neonatal anthropometric charts: what they are, what they are not. Arch Dis Child Fetal Neonatal Ed (2007) 1.66
Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology (1996) 1.66
Increased allergen-specific, steroid-sensitive gamma delta T cells in bronchoalveolar lavage fluid from patients with asthma. Ann Intern Med (1996) 1.61
Double pylorus: report of two cases and review of the literature. Ital J Gastroenterol (1992) 1.60
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther (2006) 1.58
hnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res (1993) 1.58
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51
A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut (2000) 1.48
Italian cross-sectional growth charts for height, weight and BMI (6-20 y). Eur J Clin Nutr (2002) 1.46
Ethanol-specific impairment of T-lymphocyte activation is caused by a transitory block in signal-transduction pathways. Gastroenterology (1993) 1.45
Editorial: hyponatremia - a possible but forgotten consequence of bowel preparation for colonoscopy. Aliment Pharmacol Ther (2014) 1.45
Bone loss in response to long-term glucocorticoid therapy. Bone Miner (1990) 1.44
The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats. Neurogastroenterol Motil (2008) 1.44
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut (2008) 1.43
Editorial: adequate management may reduce the colorectal cancer risk associated with constipation. Aliment Pharmacol Ther (2014) 1.42
Do Behçet's syndrome patients with acne and arthritis comprise a true subset? Comment on the article by Hatemi et al. Arthritis Rheum (2009) 1.40
Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens. J Rheumatol (1995) 1.39
Unilateral posterior crossbite is not associated with TMJ clicking in young adolescents. J Dent Res (2007) 1.37
Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci (1986) 1.37
Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology (1993) 1.35
Coeliac disease: a histological follow-up study. Histopathology (2007) 1.25
Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial. Ann Oncol (2003) 1.25
Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther (2008) 1.24
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. Hepatology (1998) 1.22
Collagen type I synthesized by pancreatic periacinar stellate cells (PSC) co-localizes with lipid peroxidation-derived aldehydes in chronic alcoholic pancreatitis. J Pathol (2000) 1.20
A new criterion for selection of pharmacokinetic multiexponential equations. J Pharm Sci (1988) 1.19
Expression of platelet-derived growth factor in a model of acute liver injury. Hepatology (1994) 1.17
Cellular localization of procollagen gene transcripts in inflammatory bowel diseases. Gastroenterology (1992) 1.17
Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol (1997) 1.17
Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 1.14
Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1. J Hepatol (2001) 1.14
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil (2014) 1.14
Method for prolonged ambulatory monitoring of high-amplitude propagated contractions from colon. Am J Physiol (1991) 1.13
Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms. Gut (2004) 1.12
Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol (1996) 1.11
Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil (2008) 1.10
Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. Hepatology (1995) 1.08
The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern. Ital J Gastroenterol Hepatol (1997) 1.07
Celiac disease and Hp infection association in Iran. Rev Esp Enferm Dig (2009) 1.05
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study. Kidney Int (1996) 1.03
Identification of muscarinic receptor subtype mediating colonic response to eating. Dig Dis Sci (1985) 1.03
Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. J Investig Med (1999) 1.02
Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. J Hepatol (1999) 1.01
Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor. Hepatology (1999) 1.01
Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol (2000) 1.01
Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest (1997) 1.00
Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype. Diabetes Metab Res Rev (2005) 1.00
School-administered weekly iron-folate supplements improve hemoglobin and ferritin concentrations in Malaysian adolescent girls. Am J Clin Nutr (1999) 1.00
Postnatal weight increase and growth velocity of very low birthweight infants. Arch Dis Child Fetal Neonatal Ed (2006) 0.98
Experience with a new device for pathological assessment of colonic endoscopic submucosal dissection. Tech Coloproctol (2014) 0.98
Growth of fetal lean mass and fetal fat mass in gestational diabetes. Ultrasound Obstet Gynecol (2010) 0.98
Upper gastrointestinal motor abnormalities in children with active celiac disease. J Pediatr Gastroenterol Nutr (1995) 0.97
Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol (1999) 0.97
Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly. Anticancer Res (1995) 0.97
Fetal growth velocity: kinetic, clinical, and biological aspects. Arch Dis Child Fetal Neonatal Ed (1996) 0.97
Phase-locked white-light continuum pulses: toward a universal optical frequency-comb synthesizer. Opt Lett (2000) 0.96
Sensory retraining is key to biofeedback therapy for formed stool fecal incontinence. Am J Gastroenterol (2002) 0.96
Duodenal ferritin synthesis in genetic hemochromatosis. Gastroenterology (1995) 0.96
Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells. Life Sci (1994) 0.95
The role of antibodies and serum complement in the interaction between macrophages and leptospires. J Gen Microbiol (1982) 0.95
Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice. Gut (2005) 0.95
Periodontal tissue disposition of azithromycin. J Periodontol (1997) 0.95
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil (2013) 0.94
Transition from nutcracker esophagus to diffuse esophageal spasm. Am J Gastroenterol (1985) 0.94
Control of enteric neuromuscular functions by purinergic A(3) receptors in normal rat distal colon and experimental bowel inflammation. Br J Pharmacol (2010) 0.94
Adaptive detection of arbitrarily shaped ultrashort quantum light states. Phys Rev Lett (2012) 0.94
The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides. Eur J Clin Invest (2003) 0.94
In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis. J Hepatol (1997) 0.93
Temporal and spatial patterns of proto-oncogene expression at early stages of toxic liver injury in the rat. Lab Invest (1991) 0.93
Heterogeneity of liver cells expressing procollagen types I and IV in vivo. Histochem Cell Biol (1997) 0.93
Anorectal dysfunction in constipated women with anorexia nervosa. Mayo Clin Proc (2000) 0.93
Collagenous colitis: a case series with confocal laser microscopy and histology correlation. Endoscopy (2008) 0.92
Wegener's granulomatosis arising in pregnancy. J Laryngol Otol (1986) 0.92
Transverse and sigmoid colon motility in healthy humans: effects of eating and of cimetropium bromide. Digestion (1987) 0.92
Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. J Clin Gastroenterol (1995) 0.91
Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study. J Clin Invest (1994) 0.90
Redefining the intraepithelial lymphocytes threshold to diagnose gluten sensitivity in patients with architecturally normal duodenal histology. Aliment Pharmacol Ther (2011) 0.90
Confocal laser endomicroscopy in celiac disease: description of findings in two cases. Endoscopy (2007) 0.90
Gluten-free diet normalizes mouth-to-cecum transit of a caloric meal in adult patients with celiac disease. Dig Dis Sci (1997) 0.89
Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. Aliment Pharmacol Ther (1997) 0.89
Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system. Growth Factors (2001) 0.89
Breath alkanes determination in ulcerative colitis and Crohn's disease. Dis Colon Rectum (1999) 0.89
Turner's syndrome in Italy: familial characteristics, neonatal data, standards for birth weight and for height and weight from infancy to adulthood. Acta Paediatr (1994) 0.89
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.89
Local expansion of allergen-specific CD30+Th2-type gamma delta T cells in bronchial asthma. Mol Med (1995) 0.89
Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors? Naunyn Schmiedebergs Arch Pharmacol (1998) 0.89
Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital J Gastroenterol (1994) 0.88